Future studies should address the relationship between increased EP24.15 expression and enzymatic activity to generate GnRH-(1–5) to all its related markers identified to ascertain its role in driving cancer progression since a prior study has implicated augmented EP24.15 activity in prostate cancer (29). Here, GNRH1 is linked to prostate carcinoma.